AAAAAA

   
Results: 1-9 |
Results: 9
THERAPY OF A XENOGRAFTED HUMAN COLONIC-CARCINOMA USING CISPLATIN OR DOXORUBICIN ENCAPSULATED IN LONG-CIRCULATING PEGYLATED STEALTH LIPOSOMES
Authors: VAAGE J DONOVAN D WIPFF E ABRA R COLBERN G USTER P WORKING P
Citation: J. Vaage et al., THERAPY OF A XENOGRAFTED HUMAN COLONIC-CARCINOMA USING CISPLATIN OR DOXORUBICIN ENCAPSULATED IN LONG-CIRCULATING PEGYLATED STEALTH LIPOSOMES, International journal of cancer, 80(1), 1999, pp. 134-137
INHIBITION OF MOUSE MAMMARY-CARCINOMA DEVELOPMENT WITH DOXORUBICIN INLIPOSOMES
Authors: VAAGE J WORKING P USTER P
Citation: J. Vaage et al., INHIBITION OF MOUSE MAMMARY-CARCINOMA DEVELOPMENT WITH DOXORUBICIN INLIPOSOMES, International journal of cancer, 75(1), 1998, pp. 158-159
TUMOR UPTAKE OF DOXORUBICIN IN POLYETHYLENE GLYCOL-COATED LIPOSOMES AND THERAPEUTIC EFFECT AGAINST A XENOGRAFTED HUMAN PANCREATIC-CARCINOMA
Authors: VAAGE J DONOVAN D USTER P WORKING P
Citation: J. Vaage et al., TUMOR UPTAKE OF DOXORUBICIN IN POLYETHYLENE GLYCOL-COATED LIPOSOMES AND THERAPEUTIC EFFECT AGAINST A XENOGRAFTED HUMAN PANCREATIC-CARCINOMA, British Journal of Cancer, 75(4), 1997, pp. 482-486
DOXORUBICIN ENCAPSULATED IN LIPOSOMES CONTAINING SURFACE-FOUND POLYETHYLENE-GLYCOL - PHARMACOKINETICS, TUMOR-LOCALIZATION, AND SAFETY IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA
Authors: NORTHFELT DW MARTIN FJ WORKING P VOLBERDING PA RUSSELL J NEWMAN M AMANTEA MA KAPLAN LD
Citation: Dw. Northfelt et al., DOXORUBICIN ENCAPSULATED IN LIPOSOMES CONTAINING SURFACE-FOUND POLYETHYLENE-GLYCOL - PHARMACOKINETICS, TUMOR-LOCALIZATION, AND SAFETY IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA, Journal of clinical pharmacology, 36(1), 1996, pp. 55-63
PROPHYLAXIS AND THERAPY OF MOUSE MAMMARY CARCINOMAS WITH DOXORUBICIN AND VINCRISTINE ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES
Authors: VAAGE J DONOVAN D LOFTUS T USTER P WORKING P
Citation: J. Vaage et al., PROPHYLAXIS AND THERAPY OF MOUSE MAMMARY CARCINOMAS WITH DOXORUBICIN AND VINCRISTINE ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES, European journal of cancer, 31A(3), 1995, pp. 367-372
PREVENTION OF METASTASIS FROM MOUSE MAMMARY CARCINOMAS WITH LIPOSOMESCARRYING DOXORUBICIN
Authors: VAAGE J DONOVAN D LOFTUS T WORKING P
Citation: J. Vaage et al., PREVENTION OF METASTASIS FROM MOUSE MAMMARY CARCINOMAS WITH LIPOSOMESCARRYING DOXORUBICIN, British Journal of Cancer, 72(5), 1995, pp. 1074-1075
CHEMOPREVENTION AND THERAPY OF MOUSE MAMMARY CARCINOMAS WITH DOXORUBICIN ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES
Authors: VAAGE J DONOVAN D LOFTUS T ABRA R WORKING P HUANG A
Citation: J. Vaage et al., CHEMOPREVENTION AND THERAPY OF MOUSE MAMMARY CARCINOMAS WITH DOXORUBICIN ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES, Cancer, 73(9), 1994, pp. 2366-2371
TISSUE DISTRIBUTION AND THERAPEUTIC EFFECT OF INTRAVENOUS FREE OR ENCAPSULATED LIPOSOMAL DOXORUBICIN ON HUMAN PROSTATE CARCINOMA XENOGRAFTS
Authors: VAAGE J BARBERAGUILLEM E ABRA R HUANG A WORKING P
Citation: J. Vaage et al., TISSUE DISTRIBUTION AND THERAPEUTIC EFFECT OF INTRAVENOUS FREE OR ENCAPSULATED LIPOSOMAL DOXORUBICIN ON HUMAN PROSTATE CARCINOMA XENOGRAFTS, Cancer, 73(5), 1994, pp. 1478-1484
LOCALIZATION OF INHIBIN AND ACTIVIN-BINDING SITES IN THE TESTIS DURING DEVELOPMENT BY IN-SITU LIGAND-BINDING
Authors: KRUMMEN LA MOORE A WOODRUFF TK COVELLO R TAYLOR R WORKING P MATHER JP
Citation: La. Krummen et al., LOCALIZATION OF INHIBIN AND ACTIVIN-BINDING SITES IN THE TESTIS DURING DEVELOPMENT BY IN-SITU LIGAND-BINDING, Biology of reproduction, 50(4), 1994, pp. 734-744
Risultati: 1-9 |